Ma Yan Huang

TL;DR: This study could identify the differentiated miRNAs expression profile in BC and reveal that miR-21 overexpression was correlated with specific breast cancer biopathologic features, such as advanced tumor stage, lymph node metastasis, and poor survival of the patients, indicating that miD-21 may serve as a molecular prognostic marker for BC and disease progression.

TL;DR: It is reported that miR-125b is downregulated in invasive breast cancers where it predicts poor patient survival and is suggested as a potential theranostic tool in this disease.

TL;DR: Multivariate analysis indicated that both survivin and VEGF over-expression in NPC tumor tissues were strong independent factors of poor prognosis in NPC patients, and suggest that tumor survivIn and V EGF expressions are valuable prognostic markers for prognosis prediction in NPC Patients.

TL;DR: As a powerful predictor of 5-year DSS among patients with NPC, the newly developed NPC-SVM classifier based on tumor-associated biomarkers will facilitate patient counseling and individualize management of patients with NPCs.

TL;DR: The proposed histopathologic classification of nasopharyngeal carcinoma offers more information for the prediction of NPC prognosis compared with the WHO classification and might be a valuable tool to guide treatment decisions for subtypes that are associated with a poor prognosis.